VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
48 hedge funds and large institutions have $19.4M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
80% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 10
Holders
48
Holding in Top 10
1
Calls
$7K
Puts
$3K
Top Buyers
| 1 | +$249K | |
| 2 | +$49.7K | |
| 3 | +$44.5K | |
| 4 |
B
Bailard
Foster City,
California
|
+$31.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.6K |
Top Sellers
| 1 | -$87.8K | |
| 2 | -$85.1K | |
| 3 | -$75.7K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$75.4K |
| 5 |
Two Sigma Investments
New York
|
-$71.9K |